Sun Pharma Launches Osmotic Delivery Formulation Of Methylphenidate In Canada

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Sun Pharmaceutical Industries (SUNPHARMA.NS) announced the commercial availability of Taro-Methylphenidate ER for Canadian patients in Ontario and Quebec. Taro-Methylphenidate ER is the only bioequivalent to Concerta with an osmotic delivery system indicated for…